SBAR yields 12.31% · JNJ yields 2.13%● Live data
📍 SBAR pulled ahead of the other in Year 1
Combined, SBAR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SBAR + JNJ for your $10,000?
The Simplify Barrier Income ETF (SBAR) seeks to offer a distinct source of monthly income by selling a 30-barrier put option. In exchange for accepting the risk of a loss defined by the 30-barrier level, investors can expect higher levels of income than can be found in traditional fixed income products.And unlike traditional bond or equity funds, the downside threshold is defined ahead of time, allowing investors to make an informed investment decision based on a quantifiable personal risk level.
Full SBAR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.